Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma

被引:24
作者
Aaberg, T. M., Jr. [1 ,2 ]
Bergstrom, C. S. [3 ]
Hickner, Z. J. [4 ]
Lynn, M. J. [5 ]
机构
[1] Associated Retinal Consultants, Grand Rapids, MI 49546 USA
[2] Michigan State Univ, Sch Med, Grand Rapids, MI USA
[3] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA
[4] Michigan State Univ, Sch Med, Lansing, MI USA
[5] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA USA
关键词
D O I
10.1136/bjo.2007.132951
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims: This is a long-term follow-up report investigating primary transpupillary thermal therapy (TTT) for choroidal melanoma. Methods: Retrospective case series of 135 patients harbouring choroidal melanoma treated with primary TTT. Patient demographics, tumour characteristics, treatment responses and complications, visual acuity outcomes and mortality data were captured and reported. A statistical analysis was performed for predictors of treatment failure. Results: Successful tumour regression was achieved in 76% of patients. Of the 32 patients who failed, 12 had enucleation, and 20 had irradiation. Metastatic disease has occurred in three patients, and two patients have died (3/135, or 2%). Multivariate analysis determined that tumour diameter, tumour thickness greater than 3 mm and tumours exhibiting high-risk characteristics were significant predictors of failure. Patient age, gender, number of treatments and proximity of the tumour to the disc or fovea were not predictive of failure. Kaplan-Meier cumulative probability predicted a 19% 5-year treatment failure and 33% 10-year treatment failure. Treatment failure occurred as late as 99 months. Final visual acuity was 20/40 or better in 50% of patients; 32% had a final visual acuity of 20/200 or worse. Thirty-two per cent of patients developed one or more complications as a result of the TTT, the most concerning of which was intra- or extrascleral extension of tumour (occurring in 11 patients). Conclusions: Though not as successful as radiation therapy, TTT successfully induced regression in 76% of patients. TTT may still have a role in our treatment paradigm but should probably be reserved for specific cases, such as monocular patients with tumours near critical visual structures, surgically unstable patients or patients with advanced diabetic retinopathy. All patients considering TTT as monotherapy for choroidal melanoma must be selected, counselled and followed appropriately.
引用
收藏
页码:741 / 746
页数:6
相关论文
共 16 条
[1]  
BUTLER P, 1994, OPHTHALMOLOGY, V101, P710
[2]  
De Potter P, 2001, J FR OPHTALMOL, V24, P937
[3]   Transpupillary thermotherapy for small choroidal melanoma [J].
Godfrey, DG ;
Waldron, RG ;
Capone, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1999, 128 (01) :88-93
[4]  
Gragoudas Evangelos S, 2002, Trans Am Ophthalmol Soc, V100, P43
[5]   Histopathological findings in human choroidal melanomas after transpupillary thermotherapy [J].
JourneedeKorver, JG ;
Oosterhuis, JA ;
deWolffRouendaal, D ;
Kemme, H .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (03) :234-239
[6]   Survival after proton-beam irradiation of uveal melanomas [J].
Kodjikian, L ;
Roy, P ;
Rouberol, F ;
Garweg, JG ;
Chauvel, P ;
MaN'On, L ;
Jean-Louis, B ;
Little, RE ;
Sasco, AJ ;
Grange, JD .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (06) :1002-1010
[7]   Changing concepts in the management of choroidal melanoma [J].
Robertson, DA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (01) :161-170
[8]  
Robertson DM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1512
[9]   Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases - Outcomes and limitations [J].
Shields, CL ;
Shields, JA ;
Perez, N ;
Singh, AD ;
Cater, J .
OPHTHALMOLOGY, 2002, 109 (02) :225-234
[10]   Combination of clinical factors predictive of growth of small choroidal melanocytic tumors [J].
Shields, CL ;
Cater, J ;
Shields, JA ;
Singh, AD ;
Santos, MCM ;
Carvalho, C .
ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (03) :360-364